Back To School With Scrip's Pharma News Test
This article was originally published in Scrip
Why should stationers and uniform suppliers have all the fun? Scrip too has decided to join the New School Year festivities and ride the wave of enthusiasm for learning and knowledge that grips pupils in countries around the world at this point in the calendar.
Put your youngsters on the bus and celebrate with our five-minute Back-to-School Pharma Grade Assessment Test.
Let your bench mate check your answers, or find them yourself on our website or in the pages of last week's issue No. 3767, where this quiz first appeared on page 2. Remember: if you cheat, you're only cheating yourself.
1) Which company has just been bought for $17bn?
a) Hospira
b) Perrigo
c) Baxalta
2) What's the annual price of one of the newly approved PCSK9 inhibitors in the US?
a) $10,000-$11,000
b) $14,000-$15,000
c) $19,000-$20,000
3) How many REMS plans has the FDA approved since gaining the authority to require them in 2007?
a) >50
b) >80
c) >110
For a bonus point, what does REMS stand for?
4) What is the brand name for Roche/Exelixis' cobimetinib, which has received its first regulatory approval for melanoma, in Switzerland?
a) Cotellic
b) Rocobo
c) Xcoban
5) Which country's government has just enraged Roche by declaring it will reimburse the latter's cancer drug Avastin for off-label use to treat the eye condition AMD and wants the company to implement a monitoring system?
a) India
b) France
c) Italy
6) ONLINE BONUS QUESTION: For what has Novo Nordisk announced an investment of $2bn?
a) A new production site for diabetes drugs
b) Early research into diabetes and obesity
c) Expanding its commercial reach in emerging markets
7) Who is Sean Bohen?
a) Beheaded lord in Game of Thrones
b) The star of Milk and Mystic River
c) AstraZeneca's latest casting for Chief Medical Officer